Cellestia presented its poster at SOHC – Swiss Oncology and Hematology Congress

Cellestia presented at SOHC  in Zurich on 18-20 Nov 2021 “A novel CSL-NICD inhibitor for the treatment of NOTCH-driven T-cell acute lymphoblastic leukemia: a case report.” Medinger M, Junker T, Halter J, Heim D, Tzankov A, Bobadilla M, Vogl FD, Bauer M, Passweg J.

To read the poster please click here.